William F Doyle Novo Cure LTD (NVCR) insider trading activity

William F Doyle is Executive Chairman of NovoCure Ltd. Currently has a direct ownership of 551,176 shares of NVCR, which is worth approximately $16.6 Million. The most recent transaction as insider was on Aug 02, 2022, when has been sold 837 shares (Ordinary Shares) at a price of $69.66 per share, resulting in proceeds of $58,305. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 551K

0% 3M change

0% 12M change

Total Value Held $16.6 Million

WILLIAM F DOYLE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 02 2022	SELL Open market or private sale	$58,305 $69.66 p/Share	837 Reduced 0.15%	551,176 Ordinary Shares
Mar 08 2022	SELL Open market or private sale	$167,188 $70.1 p/Share	2,385 Reduced 0.43%	552,013 Ordinary Shares
Aug 02 2021	SELL Open market or private sale	$148,633 $149.38 p/Share	995 Reduced 0.18%	554,398 Ordinary Shares
Apr 13 2021	SELL Open market or private sale	$19,294,501 $203.1 p/Share	95,000 Reduced 14.61%	555,393 Ordinary Shares
Apr 01 2021	SELL Open market or private sale	$1,063,303 $134.12 p/Share	7,928 Reduced 1.2%	650,393 Ordinary Shares
Mar 31 2021	BUY Exercise of conversion of derivative security	$1,159,690 $125.25 p/Share	9,259 Added 1.39%	658,321 Ordinary Shares

Also insider at

NERV

Minerva Neurosciences, Inc. Healthcare

Director

ELAN

Elanco Animal Health Inc Healthcare

DNAC

Social Capital Suvretta Holdings Corp. III

WFD

William F Doyle

Executive Chairman

Winston Salem, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVCR shares.

Notify only if

Value

Insider Trading

Get notified when an Novo Cure LTD insider buys or sells NVCR shares.

Notify only if

Operation

Value

Type

News

Receive news related to NovoCure Ltd

Track Activities on NVCR

Account